norethindrone acetate transdermal - Latest Advances

Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials.

Journal: Clinical therapeutics

Published: May 18, 2023

Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.

Journal: Menopause (New York, N.Y.)

Published: March 30, 2016

Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.

Journal: Annals of agricultural and environmental medicine : AAEM

Published: March 18, 2015

Does the use of TachoSil allow to reduce the morbidity of axillary dissection?

Journal: Gynecologie, obstetrique & fertilite

Published: February 05, 2013

Interest of a thrombin and fibrinogen combipatch in preventing breast cancer seroma after lymph node dissection

Journal: Gynecologie, obstetrique & fertilite

Published: January 20, 2013

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.

Journal: Climacteric : the journal of the International Menopause Society

Published: January 30, 2009

Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.

Journal: The journal of sexual medicine

Published: February 29, 2008

Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.

Journal: Menopause (New York, N.Y.)

Published: June 28, 2007

Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 02, 2007

Hormonal therapy with patch or pill: how much does it matter?

Journal: Thrombosis and haemostasis

Published: March 30, 2007

Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?

Journal: Thrombosis and haemostasis

Published: March 30, 2007

Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.

Journal: Climacteric : the journal of the International Menopause Society

Published: November 04, 2006

Filters

Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials.

Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials.

Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.

Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.

Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.

Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.

Does the use of TachoSil allow to reduce the morbidity of axillary dissection?

Does the use of TachoSil allow to reduce the morbidity of axillary dissection?

Interest of a thrombin and fibrinogen combipatch in preventing breast cancer seroma after lymph node dissection

Interest of a thrombin and fibrinogen combipatch in preventing breast cancer seroma after lymph node dissection

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.

Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.

Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.

Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.

Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.

Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.

Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.

Hormonal therapy with patch or pill: how much does it matter?

Hormonal therapy with patch or pill: how much does it matter?

Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?

Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?

Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.

Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.